药康生物：累计回购公司股份1067387股

Core Viewpoint - The company announced a share buyback program, indicating a commitment to returning value to shareholders and potentially signaling confidence in its future performance [2] Group 1 - As of July 31, 2025, the company has repurchased a total of 1,067,387 shares [2] - The repurchased shares represent 0.2603% of the company's total share capital of 410,000,000 shares [2]